Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8744986rdf:typepubmed:Citationlld:pubmed
pubmed-article:8744986lifeskim:mentionsumls-concept:C0031667lld:lifeskim
pubmed-article:8744986lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:8744986lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:8744986lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:8744986lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:8744986lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:8744986lifeskim:mentionsumls-concept:C0146792lld:lifeskim
pubmed-article:8744986pubmed:issue11lld:pubmed
pubmed-article:8744986pubmed:dateCreated1996-10-24lld:pubmed
pubmed-article:8744986pubmed:abstractTextFour acidic phospholipase A2 (PLA2) isozymes named PLA2-I, II, III and IV have previously been isolated from Trimeresurus gramineus (green habu snake) venom and sequenced [Oda et al. (1991) Toxicon 29, 157; Fukagawa et al. (1992) Toxicon 30, 1131; Fukagawa et al. (1993) Toxicon 31, 957]. They contain aspartate-49 which is known to bind Ca2+, essential for catalysis. In the present study, a basic PLA2 named PLA2-V containing lysine-49 was newly isolated from the same snake venom. Its isoelectric point was 9.4 and considerably higher than those (c. 4.5) of PLA2-I-IV. PLA2-V was 1.1% as active as PLA2-I toward egg-yolk emulsion but exhibited strong myotoxicity. The amino acid sequence of PLA2-V was determined by sequencing the S-carboxamidomethylated derivative and its peptide fragments produced by enzymatic (clostripain, chymotrypsin, Achromobacter protease I and Staphylococcus aureus V8 protease) cleavages. PLA2-V consists of 122 amino acid residues and is highly homologous (72-78%) to Lys-49 PLA2s so far isolated from Viperidae snake venoms but less homologous (52%) to PLA2-I. The presence of Asn-28, which is characteristic of Lys-49 PLA2s, was confirmed.lld:pubmed
pubmed-article:8744986pubmed:languageenglld:pubmed
pubmed-article:8744986pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8744986pubmed:citationSubsetIMlld:pubmed
pubmed-article:8744986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8744986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8744986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8744986pubmed:statusMEDLINElld:pubmed
pubmed-article:8744986pubmed:monthNovlld:pubmed
pubmed-article:8744986pubmed:issn0041-0101lld:pubmed
pubmed-article:8744986pubmed:authorpubmed-author:OhnoMMlld:pubmed
pubmed-article:8744986pubmed:authorpubmed-author:OgawaTTlld:pubmed
pubmed-article:8744986pubmed:authorpubmed-author:NakaiMMlld:pubmed
pubmed-article:8744986pubmed:authorpubmed-author:HattoriSSlld:pubmed
pubmed-article:8744986pubmed:authorpubmed-author:ChangC CCClld:pubmed
pubmed-article:8744986pubmed:authorpubmed-author:ShimohigashiY...lld:pubmed
pubmed-article:8744986pubmed:authorpubmed-author:NakashimaK...lld:pubmed
pubmed-article:8744986pubmed:issnTypePrintlld:pubmed
pubmed-article:8744986pubmed:volume33lld:pubmed
pubmed-article:8744986pubmed:ownerNLMlld:pubmed
pubmed-article:8744986pubmed:authorsCompleteYlld:pubmed
pubmed-article:8744986pubmed:pagination1469-78lld:pubmed
pubmed-article:8744986pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:meshHeadingpubmed-meshheading:8744986-...lld:pubmed
pubmed-article:8744986pubmed:year1995lld:pubmed
pubmed-article:8744986pubmed:articleTitlePurification and primary structure of a myotoxic lysine-49 phospholipase A2 with low lipolytic activity from Trimeresurus gramineus venom.lld:pubmed
pubmed-article:8744986pubmed:affiliationDepartment of Chemistry, Kyushu University, Fukuoka, Japan.lld:pubmed
pubmed-article:8744986pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8744986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8744986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8744986lld:pubmed